Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02775240 · ClinicalTrials.gov registry record · Phase 1
Study of SHP620 (Maribavir) in Healthy Adults
A Phase 1 study, sponsored by Shire.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT02775240 is a Phase 1 study that has completed, run by Shire. The registered enrollment target is 18 participants.
The verdict
NCT02775240, a Phase 1 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how an investigational treatment (maribavir) is handled by the body when administered with two already approved drugs (digoxin and dextromethorphan). The study will also look at the safety and tolerability when maribavir is coadministered with digoxin and dextromethorphan versus digoxin and dextromethorphan alone.
Interventions
- DRUG Digoxin
- DRUG Maribavir
- DRUG Dextromethorphan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2016-07-21 |
| Est. Completion | 2016-09-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02775240
The ClinicalTrials.gov registry entry for NCT02775240 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Digoxin is the first listed.
NCT02775240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02775240 about?
NCT02775240 is a clinical study titled "Study of SHP620 (Maribavir) in Healthy Adults". The purpose of this study is to determine how an investigational treatment (maribavir) is handled by the body when administered with two already approved drugs (digoxin and dextromethorphan). The study will also look at the safety and tolerability when maribavir is coadministered with digoxin and de...
What is the current status of trial NCT02775240?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2016-07-21. Estimated completion is 2016-09-12.
What interventions are being tested in trial NCT02775240?
The interventions under investigation include: Digoxin (DRUG), Maribavir (DRUG), Dextromethorphan (DRUG).
Who is sponsoring clinical trial NCT02775240?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.